Evommune

EVMNNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$507.139 M

$14.08 +5.23%

Close of 7 Aug 2026

Revenue

$13.0M

#3118 by revenue

Earnings

-$68.9M

Loss-making

Shares outstanding

36,292,113

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#206BioAge LabsBIOA$537.9M
#207Relmada TherapeuticsRLMD$518.2M
#208EvommuneEVMN$507.1M
#209Tenax TherapeuticsTENX$503.0M
#210EvolusEOLS$501.3M

Where these numbers come from

Share counts and financials for Evommune are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.